NEXTGEN Bioscience
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata (NCT06104839) | NEXTGEN Bioscience | 2024-09-01 |
| A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants (NCT05079425) | NEXTGEN Bioscience | 2021-09-01 |
Track NEXTGEN Bioscience automatically
Every clearance here is in the API, with alerts when new ones post.